The University of Rochester Cancer Center is a Department of the School of Medicine and Dentistry. The Center's responsibilities include clinical and laboratory research, patient care, and postdoctoral education. The Cancer Center serves the 11-county Rochester-Finger Lakes region of upstate New York, a region of approximately 1.3 million people. The participation of five Rochester hospitals in the Center's clinical research and patient care activities represents a major programmatic strength. The Center's research activities are organized around six Established Research Programs: Adult Oncology, Behavioral Medicine, Cell Growth and Regulation, Developmental Therapeutics, Immunology, and Molecular Genetics. Developing Research Programs in Pediatric Oncology and Thoracic Oncology are designed to enhance the Center's translational activities. Support for the Cancer Center's research programs is provided by seven shared resources: An Animal Tumor Research/Xenograft, Biostatistics, Cell Separation/Flow Cytometry, Dishwashing, Experimental Pathology/Ultrastructure, NMR, and Transgenic Mouse shared resources. The past three years have been a time of major transition for the University of Rochester Cancer Center. A new Director has been appointed, and other changes in key leadership positions are also underway. This period of reorganization is viewed as a major opportunity to reshape the Cancer Center: to take maximum advantage of current strengths, to address existing weaknesses, and to develop a plan that will carry the Center into the twenty-first century. Significant resources have been committed to the Cancer Center so that the necessary changes can be implemented. An additional four years of continued support is requested for the Center. This support will provide the stability needed to complete the ongoing leadership recruitments, to strengthen the Center's research programs by recruitment of new faculty, to enhance the Center's translational research activities, and to complete the process of reasserting the Center's leadership role in the clinical and laboratory research in the University and broader community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA011198-26
Application #
2085956
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1978-02-01
Project End
1998-04-30
Budget Start
1995-05-18
Budget End
1996-04-30
Support Year
26
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Rochester
Department
Internal Medicine/Medicine
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Wei, C; Callahan, B P; Turner, M J et al. (1998) Regulation of human prostate-specific antigen gene expression in transgenic mice: evidence for an enhancer between the PSA and human glandular kallikrein-1 genes. Int J Mol Med 2:487-96
Fieler, V K (1997) Side effects and quality of life in patients receiving high-dose rate brachytherapy. Oncol Nurs Forum 24:545-53
Johnson, J E; Fieler, V K; Wlasowicz, G S et al. (1997) The effects of nursing care guided by self-regulation theory on coping with radiation therapy. Oncol Nurs Forum 24:1041-50
Ford, H L; Silver, D L; Kachar, B et al. (1997) Effect of Mts1 on the structure and activity of nonmuscle myosin II. Biochemistry 36:16321-7
Johnson, J E (1996) Coping with radiation therapy: optimism and the effect of preparatory interventions. Res Nurs Health 19:3-12
Sandhu, F A; Kim, Y; Lapan, K A et al. (1996) Expression of the C terminus of the amyloid precursor protein alters growth factor responsiveness in stably transfected PC12 cells. Proc Natl Acad Sci U S A 93:2180-5
Fieler, V K; Borch, A (1996) Results of a patient education project using a touch-screen computer. Cancer Pract 4:341-5
Dragone, L L; Barth, R K; Sitar, K L et al. (1995) Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B-cell lineage of transgenic mice increases splenic B-cell number and survival. Proc Natl Acad Sci U S A 92:626-30
Ford, H L; Salim, M M; Chakravarty, R et al. (1995) Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line. Oncogene 11:2067-75
Ford, H L; Zain, S B (1995) Interaction of metastasis associated Mts1 protein with nonmuscle myosin. Oncogene 10:1597-605

Showing the most recent 10 out of 49 publications